End-of-day quote
Shanghai S.E.
23:00:00 29/04/2024 BST
|
5-day change
|
1st Jan Change
|
10.88
CNY
|
+2.93%
|
|
+3.42%
|
+11.13%
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
9,346
|
13,130
|
14,592
|
-
|
Enterprise Value (EV)
1 |
9,346
|
13,130
|
14,592
|
14,592
|
P/E ratio
|
14.9
x
|
18
x
|
17
x
|
14.7
x
|
Yield
|
-
|
1.02%
|
13.8%
|
16.5%
|
Capitalization / Revenue
|
-
|
1.09
x
|
1.09
x
|
0.99
x
|
EV / Revenue
|
-
|
1.09
x
|
1.09
x
|
0.99
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
1.06
x
|
1.31
x
|
1.26
x
|
Nbr of stocks (in thousands)
|
1,026,983
|
1,341,173
|
1,341,173
|
-
|
Reference price
2 |
9.100
|
9.790
|
10.88
|
10.88
|
Announcement Date
|
13/01/23
|
29/03/24
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
-
|
12,070
|
13,353
|
14,688
|
EBITDA
|
-
|
-
|
-
|
-
|
EBIT
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
Net income
1 |
626.6
|
691.9
|
863
|
996
|
Net margin
|
-
|
5.73%
|
6.46%
|
6.78%
|
EPS
2 |
0.6101
|
0.5433
|
0.6400
|
0.7400
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
0.1000
|
1.500
|
1.800
|
Announcement Date
|
13/01/23
|
29/03/24
|
-
|
-
|
Fiscal Period: December |
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
2,908
|
3,123
|
3,238
|
3,433
|
3,339
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
0.0900
|
0.2470
|
0.1500
|
0.2100
|
0.1900
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
29/03/24
|
29/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
6.02%
|
7.9%
|
8.8%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
4.5%
|
4.9%
|
Assets
1 |
-
|
-
|
19,178
|
20,327
|
Book Value Per Share
2 |
-
|
9.240
|
8.330
|
8.640
|
Cash Flow per Share
2 |
-
|
1.280
|
0.6800
|
0.8000
|
Capex
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
Announcement Date
|
13/01/23
|
29/03/24
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| +11.13% | 2.02B | | +4.30% | 69.91B | | +12.55% | 9.24B | | -12.75% | 5.05B | | +42.38% | 4.47B | | +5.23% | 3.92B | | +21.52% | 2.44B | | -19.05% | 2.41B | | -28.72% | 2.23B | | +4.60% | 1.66B |
Specialty & Advanced Pharmaceuticals
|